Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Tullow Oil meets 2021 guidance; DP Eurasia sales rise

Wed, 26th Jan 2022 17:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Tullow Oil PLC - West Africa-focused oil and gas producer - For 2021, working interest oil production averages 59,200 barrels of oil per day, in line with guidance due to growth from the Jubilee field in Ghana and Simba field in Gabon. As a result, in addition to a realised oil price of USD63 per barrel, revenue is expected to be USD1.3 billion, down from USD1.40 billion in 2020. Looking ahead, 2022 production guidance is set between 55,000 to 61,000 barrels per day. However, this guidance will be adjusted following the sale of Occidental Petroleum's interest in Ghana to Kosmos Energy Ltd.

----------

DP Eurasia NV - master franchisee of the Domino's Pizza brand in Turkey, Russia, Azerbaijan and Georgia - For 2021, total systems sales increase 52% year-on-year to TRY2.38 billion, around USD175.4 million, from TRY1.60 billion, driven by strong demand in Turkey and an improved performance in Russia. On a like-for-like basis, system sales growth was 40.6% from 17.4%. Looking ahead, expects adjusted Ebitda for 2021 to be in line with expectations.

----------

Renew Holdings PLC - engineering services provider - For the first quarter ended December 31, performance is in line with management expectations, with order book standing at GBP742 million, up 9.6% from GBP677 million the same date a year before.

----------

Safestyle UK PLC - Bradford, England-based PVCu double-glazed windows provider - For the year ended January 2, underlying posttax profit is set to be ahead of market expectations, on top of revenue to rise 27% year-on-year to GBP143.3 million. Also reflects a 14% rise from the 2019 financial year. Looking ahead, expects operating conditions to improve in 2022.

----------

Real Estate Investors PLC - Midlands focused investment trust - Rent collections levels for 2021 reaches 97.8%, while occupancy at the year-end stood at 85.8%, down from 91.6% the year before.

----------

Ingenta PLC - Oxford, England-based provider of software and services to media - For 2021, expects revenue to remain flat at GBP10.1 million, but adjusted earnings before interest, tax, depreciation and amortisation at GBP1.5 million, up 25% from GBP1.2 million the year before. Will pay a final dividend of 2.0 pence per share for the year.

----------

ECSC Group PLC - Yorkshire, England and Brisbane, Australia-based cyber security services - For 2021, revenue rises 8% to GBP6.1 million from GBP5.7 million the year before, leading to expectations of positive adjusted Ebitda for the period.

----------

Zoo Digital Group PLC - Sheffield, England-based provider of cloud software and media services - For the year ending March 31, revenue is expected to be ahead of market expectations and come to at least USD57 million, a 44% rise from USD39.5 million the year before, driven by new territory launches and the return of new productions. Zoo has become the primary vendor for forthcoming European launch of a global streaming service, which is set to lead to significant orders.

----------

accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - In spite of the effect of the new Omicron variant, for 2021 the company expects revenue be at least USD124 million, ahead of management expectations, and more than doubled from USD56.1 million in 2020. Also reflects a 5.8% rise from USD117.2 million in 2019.

----------

Oakley Capital Investments Ltd - investment trust - As at December 31, net asset value per share is 538 pence, up from 403p the same date a year prior. Over the course of 2021, the trust made GBP137 million in investments, and gained GBP121 million in the share of proceeds.

----------

Bloomsbury Publishing PLC - London-based publisher -For the year ending February 28, expects pretax profit and revenue to be ahead of current market expectations, which is for pretax profit of GBP20.1 million and revenue of GBP197.1 million. For the year prior, pretax profit was GBP17.3 million, and revenue GBP185.1 million.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Revenue for the six months ended December 31 rises 75% year-on-year to GBP2.2 million from GBP1.2 million, driven by growth in product sales of Alkindi and the initial launch of Efmody in Germany, UK and Austria. Looking ahead, Efmody sales are set to accelerate significantly in the first half of 2022, on expectations of receiving pricing and formulary approvals in its target European markets.

----------

Uniphar PLC - Dublin-based healthcare services firm - Performs in line with expectations for 2021, and expects to report at least an 8% rise in gross profit, driven by a strong performance from all businesses, especially Commercial & Clinical and Product Access.

----------

Gaming Realms PLC - London-based developer and licensor of mobile focused gaming content - For 2021, expects to report a 70% year-on-year increase in adjusted Ebitda to GBP5.6 million, and a 27% rise in revenue to GBP14.5 million, driven mainly by growth from the licensing business, which has launched in two new US iGaming markets of Michigan and Pennsylvania.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
13 Nov 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
28 Oct 2020 19:08

IN BRIEF: Diurnal Taps Investors For GBP9.8 Million

IN BRIEF: Diurnal Taps Investors For GBP9.8 Million

Read more
21 Oct 2020 21:15

IN BRIEF: Diurnal's Swiss Partner Seeks Marketing Approval For Alkindi

IN BRIEF: Diurnal's Swiss Partner Seeks Marketing Approval For Alkindi

Read more
21 Oct 2020 15:40

Diurnal up as its partner advances Swiss authorisation for 'Alkindi'

(Sharecast News) - Speciality pharmaceuticals company Diurnal Group announced on Wednesday that its marketing and distribution partner in Switzerland, EffRx Pharmaceuticals, has submitted a market authorisation application to Swissmedic for the registration of 'Alkindi', or hydrocortisone granules in capsules for opening, in the country.

Read more
9 Oct 2020 16:13

Diurnal raising up to £10m in placing and open offer

(Sharecast News) - Speciality pharmaceuticals company Diurnal Group announced a proposed conditional placing with institutional investors to raise up to £8m before expenses on Friday, at a price of 60p per share, and an open offer to raise up to a further £2m.

Read more
9 Oct 2020 11:56

Diurnal Raises GBP8 Million For Product Development, Commercialisation

Diurnal Raises GBP8 Million For Product Development, Commercialisation

Read more
30 Sep 2020 14:28

IN BRIEF: Diurnal Gets US FDA Approval For Alkindi Sprinkle

IN BRIEF: Diurnal Gets US FDA Approval For Alkindi Sprinkle

Read more
15 Sep 2020 16:01

IN BRIEF: Diurnal Annual Revenue Climbs And Loss Narrows

IN BRIEF: Diurnal Annual Revenue Climbs And Loss Narrows

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
8 Sep 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Sep 2020 14:04

IN BRIEF: Diurnal Inks Two European Marketing And Distribution Pacts

IN BRIEF: Diurnal Inks Two European Marketing And Distribution Pacts

Read more
3 Sep 2020 11:35

Diurnal signs two new distribution agreements in Europe

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced two further European market and distribution agreements for its products 'Alkindi', or hydrocortisone granules in capsules for opening, and 'Chronocort', or modified release hydrocortisone, on Thursday.

Read more
10 Aug 2020 11:10

IN BRIEF: Australian Regulator Approves Diurnal Drug Alkindi

IN BRIEF: Australian Regulator Approves Diurnal Drug Alkindi

Read more
5 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

Read more
26 May 2020 17:50

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.